{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:54:56Z","timestamp":1791320096638,"version":"4.3.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01-AG045611"],"award-info":[{"award-number":["R01-AG045611"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"John Douglas French Alzheimer's Foundation"},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stichting VUMC"},{"DOI":"10.13039\/501100010573","name":"Stichting Dioraphte","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010573","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neurobiolaging.2015.04.011","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T23:28:53Z","timestamp":1430004533000},"page":"2340-2347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Rik","family":"Ossenkoppele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's\u00a0disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's\u00a0disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A\u00a0fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1159\/000314679","article-title":"CSF-tau and CSF-Abeta (1-42) in posterior cortical atrophy","volume":"29","author":"Baumann","year":"2010","journal-title":"Dement. Geriatr. Cog Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archneur.1988.00520310107024","article-title":"Posterior cortical atrophy","volume":"45","author":"Benson","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib6","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proc. Nat. Aca Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.neurobiolaging.2008.02.007","article-title":"CSF biomarker levels in early and late onset Alzheimer's disease","volume":"30","author":"Bouwman","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib10","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10072-014-1644-5","article-title":"Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy","volume":"35","author":"Coppi","year":"2014","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(11)70289-7","article-title":"Posterior cortical atrophy","volume":"11","author":"Crutch","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib13","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awr130","article-title":"Similar amyloid-beta burden in posterior cortical atrophy and Alzheimer's disease","volume":"134","author":"de Souza","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","article-title":"Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias","volume":"82","author":"de Souza","year":"2011","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib16","article-title":"Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic","author":"Duits","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib17","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/brain\/awm136","article-title":"No association of CSF biomarkers with APOE epsilon4, plaque and tangle burden in definite Alzheimer's disease","volume":"130","author":"Engelborghs","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/brain\/awl377","article-title":"The topography of grey matter involvement in early and late onset Alzheimer's disease","volume":"130","author":"Frisoni","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/brain\/123.3.484","article-title":"Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases","volume":"123","author":"Galton","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000320506.79811.da","article-title":"The logopenic\/phonological variant of primary progressive aphasia","volume":"71","author":"Gorno-Tempini","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archneur.62.5.770","article-title":"Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease","volume":"62","author":"Hampel","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib23","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1212\/WNL.0b013e3181b879ac","article-title":"Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease","volume":"73","author":"Henneman","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","article-title":"Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke","volume":"297","author":"Hesse","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer's disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib26","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archneur.56.10.1233","article-title":"Clinical and pathological evidence for a frontal variant of Alzheimer disease","volume":"56","author":"Johnson","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib27","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0b013e3181bd8271","article-title":"CSF biomarkers predict rate of cognitive decline in Alzheimer disease","volume":"73","author":"Kester","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3233\/JAD-2010-1337","article-title":"Early-versus late-onset Alzheimer's disease: more than age alone","volume":"19","author":"Koedam","year":"2010","journal-title":"J.\u00a0Alzheimer Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.46.1.136","article-title":"Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: a CERAD analysis, Part XII","volume":"46","author":"Koss","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jalz.2011.09.225","article-title":"Global gray matter changes in posterior cortical atrophy: a serial imaging study","volume":"8","author":"Lehmann","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/brain\/aws327","article-title":"Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease","volume":"136","author":"Lehmann","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3233\/JAD-131382","article-title":"Increased cerebrospinal fluid tau levels in logopenic variant of Alzheimer's disease","volume":"39","author":"Magnin","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer's Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib35","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/WNL.0b013e3182477eed","article-title":"Age and diagnostic performance of Alzheimer disease CSF biomarkers","volume":"78","author":"Mattsson","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000058331","article-title":"Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease","volume":"14","author":"Mendez","year":"2002","journal-title":"Dement. Geriatr. Cog. Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.21388","article-title":"Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia","volume":"63","author":"Mesulam","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib39","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awu024","article-title":"Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia","volume":"137","author":"Mesulam","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.0b013e3181c0d427","article-title":"Clinical syndromes associated with posterior atrophy: early age at onset AD spectrum","volume":"73","author":"Migliaccio","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib41","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","article-title":"Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease","volume":"34","author":"Moller","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","article-title":"Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease","volume":"56","author":"Mulder","year":"2010","journal-title":"Clin. Chemistry"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jalz.2012.07.003","article-title":"Impact of molecular imaging on the diagnostic process in a memory clinic","volume":"9","author":"Ossenkoppele","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib46","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ana.24321","article-title":"Tau, amyloid and hypometabolism in a patient with posterior cortical atrophy","author":"Ossenkoppele","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib47","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET","volume":"39","author":"Ossenkoppele","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/alzrt88","article-title":"Amyloid imaging in prodromal Alzheimer's disease","volume":"3","author":"Ossenkoppele","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib49","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1212\/01.wnl.0000242732.06714.0f","article-title":"Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury","volume":"67","author":"Ost","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib50","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid beta-amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib51","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.WNL.0000140290.80962.BF","article-title":"Progressive posterior cortical dysfunction: a clinicopathologic series","volume":"63","author":"Renner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.0b013e31825dce28","article-title":"Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness","volume":"79","author":"Ridgway","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib54","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.0000000000000824","article-title":"Asymmetry of cortical decline in subtypes of primary progressive aphasia","volume":"83","author":"Rogalski","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bandl.2012.12.008","article-title":"Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia","volume":"127","author":"Rohrer","year":"2013","journal-title":"Brain Lang."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib56","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0b013e31821cccad","article-title":"Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution","volume":"76","author":"Rosenbloom","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.0000000000000032","article-title":"Practical utility of amyloid and FDG-PET in an academic dementia center","volume":"82","author":"Sanchez-Juan","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib58","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3233\/JAD-141122","article-title":"Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia","volume":"43","author":"Santangelo","year":"2015","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","article-title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration","volume":"75","author":"Scherling","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib61","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/WNL.0b013e31821ccc98","article-title":"CSF biomarkers in posterior cortical atrophy","volume":"76","author":"Seguin","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry","volume":"71","author":"Skillback","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib63","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1148\/radiol.2482070938","article-title":"Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients","volume":"248","author":"Sluimer","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2012-111934","article-title":"Early onset Alzheimer's disease is associated with a distinct neuropsychological profile","volume":"30","author":"Smits","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib65","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2015.04.011_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cortex.2005.11.002","article-title":"Variability in cognitive presentation of Alzheimer's disease","volume":"44","author":"Stopford","year":"2008","journal-title":"Cortex"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib67","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/01.WNL.0000140289.18472.15","article-title":"Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy","volume":"63","author":"Tang-Wai","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000355555","article-title":"Cerebrospinal fluid biomarkers in clinical subtypes of early-onset Alzheimer's disease","volume":"37","author":"Teng","year":"2014","journal-title":"Dement. Geriatr. Cog. Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib69","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-2011-0006","article-title":"Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data","volume":"26","author":"Tosun","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3233\/JAD-132306","article-title":"Optimizing patient care and research: the Amsterdam Dementia Cohort","volume":"41","author":"van der Flier","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib71","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/01.wnl.0000345014.48839.71","article-title":"CSF biomarkers in relationship to cognitive profiles in Alzheimer disease","volume":"72","author":"van der Vlies","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib72","unstructured":"Verhage, F. 1964. Intelligentie en leeftijd: onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar [Intelligence and age: Study with Dutch people aged 12 to 77], Assen."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib73","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/brain\/aws125","article-title":"Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study","volume":"135","author":"Villain","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.011_bib75","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-132561","article-title":"Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort","volume":"41","author":"Zwan","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:42:06Z","timestamp":1589503326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0197458015002316"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725508178.793507921","asserted-by":"object"}]},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}